Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. (OTLK) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 95 transactions totaling $35.0M, demonstrating a bullish sentiment with $32.1M in net insider flow. The most recent transaction on Sep 26, 2024 involved a purchase of 5,000 shares valued at $28.4K.
OTLK Insider Activity Summary
Who Is Buying OTLK Stock?
No significant insider buying has been recorded for OTLK in the recent period.
Who Is Selling OTLK Stock?
No significant insider selling has been recorded for OTLK in the recent period.
Is Outlook Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OTLK is bullish with an Insider Alignment Score of 96/100 and a net flow of $32.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OTLK Frequently Asked Questions
Understanding OTLK Insider Activity
Insider trading at Outlook Therapeutics, Inc. (OTLK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading OTLK stock, having executed 95 transactions in the past 90 days. The most active insider is Ghiath M. Sukhtian (Executive), who has made 8 transactions totaling $47.1M.
Related Tools
Track Outlook Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OTLK file new Form 4 transactions